High-Risk Drug Monitoring Service · Harleston

High-Risk Drug Monitoring Service in Harleston.

Systematic monitoring of high-risk medicines across the practice list — DMARDs, lithium, amiodarone, anticoagulants, valproate — with pharmacist-led recall and prescribing safety reporting. Delivered to Harleston PCNs and GP practices from the BCS Chiswick (West London) hub, with paired cover from our Halifax (West Yorkshire) hub — the only UK dual-hub clinical pharmacy model.

Harleston · local context

Harleston PCNs sit within the local East of England ICB (Cambridgeshire and Peterborough, Norfolk and Waveney, Suffolk and North East Essex, Mid and South Essex, Hertfordshire and West Essex, or Bedfordshire, Luton and Milton Keynes).

Harleston PCNs combine larger market-town practices with smaller rural branches — BCS combines on-site pharmacist days with HSCN-secured remote prescribing for the smaller sites.

What you get

What high-risk drug monitoring in Harleston actually looks like.

  • Quarterly DMARD bloods recall and recording
  • Anticoagulant INR / DOAC reviews
  • Lithium and amiodarone monitoring cycles
  • Valproate Pregnancy Prevention Programme oversight
  • Safety alert action and audit evidence

Dual-hub delivery

The only UK provider with a Yorkshire + London hub.

Every high-risk drug monitoring placement in Harleston is mobilised from one of our two clinical hubs — Chiswick (West London) as the lead and Halifax (West Yorkshire) as paired cover. The dual-hub model is unique to BCS: same SOPs, same supervision, same-week cross-cover.

  • Lead delivery from the BCS Chiswick (West London) hub
  • Paired cover from BCS Halifax (West Yorkshire)
  • Same-week sickness, leave and maternity cover
  • ARRS-compliant, GPhC-registered workforce
  • One SLA, one report, one escalation point

Harleston · what good looks like

Typical first-year markers.

4–6 wks
Mobilisation in Harleston
2 hubs
Halifax + Chiswick — unique to BCS
100%
Supervision evidenced for audit
Monthly
QA-checked outcomes report

Why Harleston PCNs choose BCS for high-risk drug monitoring.

Solo recruitment for high-risk drug monitoring in Harleston leaves a network exposed to sickness, maternity and retention risk, and rarely meets the supervision standard ICBs now ask for. BCS removes all of that — pharmacists are part of a clinical team, supervision is built in, and continuity is guaranteed by the Chiswick (West London)/Halifax (West Yorkshire) dual-hub.

Frequently asked questions — High-Risk Drug Monitoring Service in Harleston.

Does BCS handle MHRA safety alert response?+

Yes — every active MHRA alert is mapped to a BCS pharmacist workflow with action evidence per practice.

Does BCS already deliver high-risk drug monitoring in Harleston?+

BCS supports PCNs across East of England from our Chiswick (West London) hub with paired cover from Halifax (West Yorkshire), and is actively delivering or available to mobilise high-risk drug monitoring in Harleston. Get in touch and we'll confirm current capacity.

How quickly can BCS mobilise high-risk drug monitoring in Harleston?+

In most cases inside 4–6 weeks of contract sign-off, with HSCN-secured remote prescribing back-up available sooner where capacity is urgent.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call